Deal Announcements

Avila Therapeutics Raises Series A Funding

Tuesday, August 21, 2007 5:00:00 AM PDT | VentureDeal Staff

WALTHAM, MA -- Biopharmaceutical company Avila Therapeutics, Inc. has secured an undisclosed amount of series A round venture capital funding.

Avila is focused on the discovery and development of small molecule therapeutics with an initial focus on cancer and viral diseases.

Investors in the round were lead investor Abingworth Management and included Advent International, Atlas Venture and Polaris Venture Partners.  Proceeds purposes were not disclosed.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1